1-4 of 4
Cheryl Langford
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Organ Damage at Initial Presentation across the Spectrum of Advanced Systemic Mastocytosis Variants

Emily C. Liang, Cecelia Perkins, Rong Lu, Justin Abuel, Cheryl Langford, Denise DeVore, Lenn Fechter, Parveen Abidi, William Shomali, Jason Gotlib
Journal: Blood
Blood (2021) 138 (Supplement 1): 2567.
https://doi.org/10.1182/blood-2021-145082
Published: 2021
Journal Articles

Comprehensive Cytokine Profiling of Patients with Advanced Systemic Mastocytosis Treated with Midostaurin

Asiri Ediriwickrema, MD, Daniel J. DeAngelo, MD, Tracy I. George, MD, Yael Rosenberg-Hasson, Cecelia Perkins, Cheryl Langford, Jason R. Gotlib, MDMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1792.
https://doi.org/10.1182/blood-2018-99-117689
Published: 2018
Journal Articles

Phase 2 Study of Brentuximab Vedotin in Patients with Advanced Systemic Mastocytosis

John H. Baird, Srdan Verstovsek, MD PhD, Tracy I. George, Isabel Reyes, Justin Abuel, Cecelia Perkins, Cheryl Langford, Kurt Schroeder, Jason Gotlib, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2909.
https://doi.org/10.1182/blood.V130.Suppl_1.2909.2909
Published: 2017
Journal Articles

KIT Inhibitor Midostaurin Exhibits a High Rate of Clinically Meaningful and Durable Responses in Advanced Systemic Mastocytosis: Report of a Fully Accrued Phase II Trial

Jason Gotlib, Daniel J. DeAngelo, Tracy I. George, Christopher L. Corless, Andrea Linder, Cheryl Langford, Catherine Dutreix, Stefan Gross, Zariana Nikolova, Timothy Graubert
Journal: Blood
Blood (2010) 116 (21): 316.
https://doi.org/10.1182/blood.V116.21.316.316
Published: 2010